We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · October 12, 2019

DPP4 Inhibitors Do Not Increase IBD Risk

Diabetes Care


Additional Info

Diabetes Care
Dipeptidyl Peptidase 4 Inhibitors and Risk of Inflammatory Bowel Disease: Real-World Evidence in U.S. Adults
Diabetes Care 2019 Aug 30;[EPub Ahead of Print], T Wang, JY Yang, JB Buse, V Pate, H Tang, EL Barnes, RS Sandler, T Stürmer

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading